US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist

49.660
+1.340+2.77%

Close Nov 26 16:00 ET

49.660
0.0000.00%

Post 20:01 ET

1.90BMarket Cap-13242P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

2,471.78%48.12M

40.81M

1,004.56%27.61M

-32.42%17.45M

30.76%13.08M

1.87M

363.82%2.5M

-54.73%25.82M

2,858.58%10M

Operating revenue

2,471.78%48.12M

--40.81M

1,004.56%27.61M

-32.42%17.45M

30.76%13.08M

--1.87M

--0

363.82%2.5M

-54.73%25.82M

2,858.58%10M

Cost of revenue

759.95%3.24M

1.65M

66.81%1.59M

204.00%1.22M

377K

-53.98%955K

1,766.67%400K

Gross profit

2,903.75%44.88M

37.81M

938.40%25.96M

-36.23%15.85M

23.54%11.86M

1.49M

394.07%2.5M

-54.76%24.86M

2,551.93%9.6M

Operating expense

65.07%70.04M

116.66%71.11M

131.84%63.64M

81.58%159.01M

128.34%56.31M

85.23%42.43M

64.28%32.82M

37.07%27.45M

30.49%87.57M

66.52%24.66M

Selling and administrative expenses

90.97%57.91M

189.97%58.79M

241.67%51.58M

141.83%108.7M

193.89%43.01M

152.83%30.32M

95.40%20.28M

89.98%15.1M

76.99%44.95M

116.08%14.63M

Research and development costs

0.19%12.13M

-1.81%12.32M

-2.35%12.07M

18.04%50.31M

32.68%13.31M

10.93%12.11M

30.65%12.55M

2.28%12.36M

2.19%42.62M

24.76%10.03M

Operating profit

38.53%-25.16M

-1.47%-33.3M

-51.03%-37.68M

-128.28%-143.16M

-195.13%-44.45M

-78.71%-40.94M

-528.27%-32.82M

-27.82%-24.95M

-415.85%-62.71M

-4.24%-15.06M

Net non-operating interest income expense

-15.49%1.68M

43.23%2.02M

32.63%2.13M

437.77%6.99M

38.61%1.99M

363.08%1.98M

671.26%1.41M

609.18%1.61M

3,511.11%1.3M

11,858.33%1.44M

Non-operating interest income

45.07%4.12M

85.53%4.13M

35.94%3.12M

195.43%10.34M

40.01%2.98M

167.67%2.84M

649.49%2.23M

--2.29M

9,619.44%3.5M

17,625.00%2.13M

Non-operating interest expense

180.73%2.32M

155.15%2.01M

44.89%949K

56.25%3.23M

44.71%958K

40.55%825K

44.67%787K

107.28%655K

--2.06M

--662K

Total other finance cost

290.91%129K

260.71%101K

17.24%34K

-10.37%121K

3.33%31K

-28.26%33K

--28K

--29K

--135K

--30K

Other net income (expense)

134.36%67K

-14,250.00%-2.01M

-138.16%-181K

140.12%274K

1,970.37%559K

-413.16%-195K

94.85%-14K

81.00%-76K

58.63%-683K

107.48%27K

Gain on sale of security

----

-118.18%-6K

-858.54%-786K

148.89%376K

642.86%572K

-374.19%-147K

108.73%33K

81.24%-82K

51.27%-769K

121.63%77K

Special income (charges)

--0

---1.94M

----

--0

----

-Less:Other special charges

----

--1.94M

----

Other non- operating income (expenses)

239.58%67K

-25.53%-59K

9,983.33%605K

-218.60%-102K

74.00%-13K

-585.71%-48K

-144.34%-47K

-83.78%6K

217.81%86K

-900.00%-50K

Income before tax

40.18%-23.42M

-5.94%-33.29M

-52.57%-35.73M

-118.85%-135.89M

-208.13%-41.9M

-73.87%-39.15M

-447.17%-31.42M

-15.72%-23.42M

-350.88%-62.1M

8.10%-13.6M

Income tax

-107.27%-4K

Net income

40.18%-23.42M

-5.94%-33.29M

-52.57%-35.73M

-118.86%-135.89M

-208.13%-41.9M

-73.91%-39.15M

-447.17%-31.42M

-15.72%-23.42M

-349.06%-62.09M

8.43%-13.6M

Net income continuous Operations

40.18%-23.42M

-5.94%-33.29M

-52.57%-35.73M

-118.86%-135.89M

-208.13%-41.9M

-73.91%-39.15M

-447.17%-31.42M

-15.72%-23.42M

-349.06%-62.09M

8.43%-13.6M

Minority interest income

Net income attributable to the parent company

40.18%-23.42M

-5.94%-33.29M

-52.57%-35.73M

-118.86%-135.89M

-208.13%-41.9M

-73.91%-39.15M

-447.17%-31.42M

-15.72%-23.42M

-349.06%-62.09M

8.43%-13.6M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

40.18%-23.42M

-5.94%-33.29M

-52.57%-35.73M

-118.86%-135.89M

-208.13%-41.9M

-73.91%-39.15M

-447.17%-31.42M

-15.72%-23.42M

-349.06%-62.09M

8.39%-13.6M

Basic earnings per share

52.34%-0.61

24.79%-0.88

-14.77%-1.01

-83.33%-4.62

-167.35%-1.31

-52.38%-1.28

-387.50%-1.17

10.20%-0.88

-276.12%-2.52

31.94%-0.49

Diluted earnings per share

52.34%-0.61

24.79%-0.88

-14.77%-1.01

-83.33%-4.62

-167.35%-1.31

-51.61%-1.28

-387.50%-1.17

10.20%-0.88

-276.12%-2.52

31.94%-0.49

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	2,471.78%48.12M	40.81M	1,004.56%27.61M	-32.42%17.45M	30.76%13.08M	1.87M	0	363.82%2.5M	-54.73%25.82M	2,858.58%10M
Operating revenue	2,471.78%48.12M	--40.81M	1,004.56%27.61M	-32.42%17.45M	30.76%13.08M	--1.87M	--0	363.82%2.5M	-54.73%25.82M	2,858.58%10M
Cost of revenue	759.95%3.24M	3M	1.65M	66.81%1.59M	204.00%1.22M	377K	0	0	-53.98%955K	1,766.67%400K
Gross profit	2,903.75%44.88M	37.81M	938.40%25.96M	-36.23%15.85M	23.54%11.86M	1.49M	0	394.07%2.5M	-54.76%24.86M	2,551.93%9.6M
Operating expense	65.07%70.04M	116.66%71.11M	131.84%63.64M	81.58%159.01M	128.34%56.31M	85.23%42.43M	64.28%32.82M	37.07%27.45M	30.49%87.57M	66.52%24.66M
Selling and administrative expenses	90.97%57.91M	189.97%58.79M	241.67%51.58M	141.83%108.7M	193.89%43.01M	152.83%30.32M	95.40%20.28M	89.98%15.1M	76.99%44.95M	116.08%14.63M
Research and development costs	0.19%12.13M	-1.81%12.32M	-2.35%12.07M	18.04%50.31M	32.68%13.31M	10.93%12.11M	30.65%12.55M	2.28%12.36M	2.19%42.62M	24.76%10.03M
Operating profit	38.53%-25.16M	-1.47%-33.3M	-51.03%-37.68M	-128.28%-143.16M	-195.13%-44.45M	-78.71%-40.94M	-528.27%-32.82M	-27.82%-24.95M	-415.85%-62.71M	-4.24%-15.06M
Net non-operating interest income expense	-15.49%1.68M	43.23%2.02M	32.63%2.13M	437.77%6.99M	38.61%1.99M	363.08%1.98M	671.26%1.41M	609.18%1.61M	3,511.11%1.3M	11,858.33%1.44M
Non-operating interest income	45.07%4.12M	85.53%4.13M	35.94%3.12M	195.43%10.34M	40.01%2.98M	167.67%2.84M	649.49%2.23M	--2.29M	9,619.44%3.5M	17,625.00%2.13M
Non-operating interest expense	180.73%2.32M	155.15%2.01M	44.89%949K	56.25%3.23M	44.71%958K	40.55%825K	44.67%787K	107.28%655K	--2.06M	--662K
Total other finance cost	290.91%129K	260.71%101K	17.24%34K	-10.37%121K	3.33%31K	-28.26%33K	--28K	--29K	--135K	--30K
Other net income (expense)	134.36%67K	-14,250.00%-2.01M	-138.16%-181K	140.12%274K	1,970.37%559K	-413.16%-195K	94.85%-14K	81.00%-76K	58.63%-683K	107.48%27K
Gain on sale of security	----	-118.18%-6K	-858.54%-786K	148.89%376K	642.86%572K	-374.19%-147K	108.73%33K	81.24%-82K	51.27%-769K	121.63%77K
Special income (charges)	--0	---1.94M	----	----	----	--0	--0	----	----	----
-Less:Other special charges	----	--1.94M	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	239.58%67K	-25.53%-59K	9,983.33%605K	-218.60%-102K	74.00%-13K	-585.71%-48K	-144.34%-47K	-83.78%6K	217.81%86K	-900.00%-50K
Income before tax	40.18%-23.42M	-5.94%-33.29M	-52.57%-35.73M	-118.85%-135.89M	-208.13%-41.9M	-73.87%-39.15M	-447.17%-31.42M	-15.72%-23.42M	-350.88%-62.1M	8.10%-13.6M
Income tax				0					-107.27%-4K	0
Net income	40.18%-23.42M	-5.94%-33.29M	-52.57%-35.73M	-118.86%-135.89M	-208.13%-41.9M	-73.91%-39.15M	-447.17%-31.42M	-15.72%-23.42M	-349.06%-62.09M	8.43%-13.6M
Net income continuous Operations	40.18%-23.42M	-5.94%-33.29M	-52.57%-35.73M	-118.86%-135.89M	-208.13%-41.9M	-73.91%-39.15M	-447.17%-31.42M	-15.72%-23.42M	-349.06%-62.09M	8.43%-13.6M
Minority interest income
Net income attributable to the parent company	40.18%-23.42M	-5.94%-33.29M	-52.57%-35.73M	-118.86%-135.89M	-208.13%-41.9M	-73.91%-39.15M	-447.17%-31.42M	-15.72%-23.42M	-349.06%-62.09M	8.43%-13.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	40.18%-23.42M	-5.94%-33.29M	-52.57%-35.73M	-118.86%-135.89M	-208.13%-41.9M	-73.91%-39.15M	-447.17%-31.42M	-15.72%-23.42M	-349.06%-62.09M	8.39%-13.6M
Basic earnings per share	52.34%-0.61	24.79%-0.88	-14.77%-1.01	-83.33%-4.62	-167.35%-1.31	-52.38%-1.28	-387.50%-1.17	10.20%-0.88	-276.12%-2.52	31.94%-0.49
Diluted earnings per share	52.34%-0.61	24.79%-0.88	-14.77%-1.01	-83.33%-4.62	-167.35%-1.31	-51.61%-1.28	-387.50%-1.17	10.20%-0.88	-276.12%-2.52	31.94%-0.49
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data